Clinical Impact of Lymphatic Spread in Patients with Limited-stage Upper Aerodigestive Tract NK/T Cell Lymphoma

Overview

Journal Blood Res

Publisher Springer Nature

Specialty Hematology

Date 2021 May 25

PMID 34031274

Authors

Moo-Kon Song

Joo-Seop Chung

Sung-Yong Oh

Sung-Nam Lim

Won-Sik Lee

Sang-Min Lee

Do-Young Kim

Affiliations

Soon will be listed here.

Abstract

Background: We investigated whether distance, that is, the degree of distance between the upper aerodigestive tract (UAT) mass and the farthest pathologic lymph node, was significantly associated with survival in patients with limited-stage UAT natural killer/T cell lymphoma (NKTCL).

Methods: A total of 157 patients who received chemotherapy (CTx) with/without radiotherapy (RTx) were enrolled.

Results: In the survival analysis, an elevated lactate dehydrogenase level [progression-free survival (PFS): hazard ratio (HR), 2.948; 95% confidence interval (CI), 1.606‒5.404; <0.001; overall survival (OS): HR, 2.619; 95% CI, 1.594‒4.822; =0.003], short distance (PFS: HR, 0.170; 95% CI, 0.071‒0.410; <0.001; OS: HR, 0.142; 95% CI, 0.050‒0.402; < 0.001), and CTx combined with RTx (HR, 0.168; 95%CI, 0.079‒0.380; <0.001; OS: HR, 0.193; 95% CI, 0.087‒0.429; <0.001) had an independent predictive value for PFS and OS.

Conclusion: The evaluation of the degree of lymphatic spread and local control by CTx combined with RTx is essential in patients with limited-stage UAT NKTCL.

References

Jo J, Yoon D, Kim S, Lee B, Jang Y, Park C . Clinical features and prognostic model for extranasal NK/T-cell lymphoma. Eur J Haematol. 2012; 89(2):103-10. DOI: 10.1111/j.1600-0609.2012.01796.x. View

You J, Chi K, Yang M, Chen C, Ho C, Chau W . Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan. Ann Oncol. 2004; 15(4):618-25. DOI: 10.1093/annonc/mdh143. View

Suzuki R, Suzumiya J, Yamaguchi M, Nakamura S, Kameoka J, Kojima H . Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type. Ann Oncol. 2009; 21(5):1032-40. DOI: 10.1093/annonc/mdp418. View

Logsdon M, Ha C, Kavadi V, Cabanillas F, Hess M, Cox J . Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy. Cancer. 1997; 80(3):477-88. DOI: 10.1002/(sici)1097-0142(19970801)80:3<477::aid-cncr16>3.0.co;2-u. View

Cheson B, Horning S, Coiffier B, Shipp M, Fisher R, Connors J . Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol. 1999; 17(4):1244. DOI: 10.1200/JCO.1999.17.4.1244. View

Li C, Tien H, Tang J, Yao M, Chen Y, Su I . Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma. Cancer. 2004; 100(2):366-75. DOI: 10.1002/cncr.11908. View

Lee J, Suh C, Park Y, Ko Y, Bang S, Lee J . Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol. 2005; 24(4):612-8. DOI: 10.1200/JCO.2005.04.1384. View

Kim T, Lee S, Jeon Y, Ryoo B, Cho G, Hong Y . Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group. Ann Oncol. 2008; 19(8):1477-1484. DOI: 10.1093/annonc/mdn147. View

Kim T, Park Y, Lee S, Kim J, Kim D, Im S . Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type. Blood. 2005; 106(12):3785-90. DOI: 10.1182/blood-2005-05-2056. View

10.

Lee J, Park Y, Kim W, Lee S, Ryoo B, Yang S . Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy. Eur J Cancer. 2005; 41(10):1402-8. DOI: 10.1016/j.ejca.2005.03.010. View

11.

Ko Y, Cho E, Kim J, Lee S, Huh J, Chang H . NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status. Histopathology. 2004; 44(5):480-9. DOI: 10.1111/j.1365-2559.2004.01867.x. View

12.

Kim S, Yoon D, Jaccard A, Chng W, Lim S, Hong H . A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncol. 2016; 17(3):389-400. DOI: 10.1016/S1470-2045(15)00533-1. View

13.

Chan J, Lim S . Novel findings from the Asian Lymphoma Study Group: focus on T and NK-cell lymphomas. Int J Hematol. 2018; 107(4):413-419. DOI: 10.1007/s12185-018-2406-6. View

14.

Kim K, Kim W, Jung C, Im Y, Kang W, Lee M . Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma (REAL) classification. Eur J Cancer. 2001; 38(1):75-81. DOI: 10.1016/s0959-8049(01)00344-6. View

15.

Aviles A, Diaz N, Neri N, Cleto S, Talavera A . Angiocentric nasal T/natural killer cell lymphoma: a single centre study of prognostic factors in 108 patients. Clin Lab Haematol. 2000; 22(4):215-20. DOI: 10.1046/j.1365-2257.2000.00307.x. View

16.

Cheung M, Chan J, Lau W, Ngan R, Foo W . Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys. 2002; 54(1):182-90. DOI: 10.1016/s0360-3016(02)02916-4. View

17.

Li Y, Fang H, Liu Q, Lu J, Qi S, Wang H . Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring. Blood. 2008; 112(8):3057-64. DOI: 10.1182/blood-2008-05-160176. View

18.

Au W, Weisenburger D, Intragumtornchai T, Nakamura S, Kim W, Sng I . Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood. 2008; 113(17):3931-7. DOI: 10.1182/blood-2008-10-185256. View

19.

Chim C, Ma S, Au W, Choy C, Lie A, Liang R . Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood. 2003; 103(1):216-21. DOI: 10.1182/blood-2003-05-1401. View

20.

Yan Z, Huang H, Wang X, Gao Y, Zhang Y, Bai B . A TNM Staging System for Nasal NK/T-Cell Lymphoma. PLoS One. 2015; 10(6):e0130984. PMC: 4476596. DOI: 10.1371/journal.pone.0130984. View